886 related articles for article (PubMed ID: 29110281)
21. Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients.
Karadağ C; Yoldemir T; Yavuz DG
J Obstet Gynaecol Res; 2018 Feb; 44(2):270-277. PubMed ID: 29094433
[TBL] [Abstract][Full Text] [Related]
22. The effect of alfacalcidiol and metformin on metabolic disturbances in women with polycystic ovary syndrome.
Figurová J; Dravecká I; Petríková J; Javorský M; Lazúrová I
Horm Mol Biol Clin Investig; 2017 Mar; 29(3):85-91. PubMed ID: 28157691
[TBL] [Abstract][Full Text] [Related]
23. The Effect of Oligopin Supplementation on Hormonal and Metabolic Profiles in the Polycystic Ovary Syndrome: A Randomized Controlled Trial.
Qorbani M; Sanginabadi M; Mohajeri-Tehrani MR; Karimi S; Gerami H; Mahdavi-Gorabi A; Shirzad N; Samadi M; Baygi F; Hosseini S; Mansour A
Front Endocrinol (Lausanne); 2020; 11():590392. PubMed ID: 33408691
[TBL] [Abstract][Full Text] [Related]
24. Neck circumference a good predictor of raised insulin and free androgen index in obese premenopausal women: changes with weight loss.
Dixon JB; O'Brien PE
Clin Endocrinol (Oxf); 2002 Dec; 57(6):769-78. PubMed ID: 12460327
[TBL] [Abstract][Full Text] [Related]
25. Does a restricted energy low glycemic index diet have a different effect on overweight women with or without polycystic ovary syndrome?
Shishehgar F; Mirmiran P; Rahmati M; Tohidi M; Ramezani Tehrani F
BMC Endocr Disord; 2019 Sep; 19(1):93. PubMed ID: 31477085
[TBL] [Abstract][Full Text] [Related]
26. Effects of selenium supplementation on glucose homeostasis and free androgen index in women with polycystic ovary syndrome: A randomized, double blinded, placebo controlled clinical trial.
Mohammad Hosseinzadeh F; Hosseinzadeh-Attar MJ; Yekaninejad MS; Rashidi B
J Trace Elem Med Biol; 2016 Mar; 34():56-61. PubMed ID: 26854246
[TBL] [Abstract][Full Text] [Related]
27. Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.
Maktabi M; Jamilian M; Asemi Z
Biol Trace Elem Res; 2018 Mar; 182(1):21-28. PubMed ID: 28668998
[TBL] [Abstract][Full Text] [Related]
28. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
[TBL] [Abstract][Full Text] [Related]
29. Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study.
Mehrabani HH; Salehpour S; Amiri Z; Farahani SJ; Meyer BJ; Tahbaz F
J Am Coll Nutr; 2012 Apr; 31(2):117-25. PubMed ID: 22855917
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D Supplementation Decreases TGF-β1 Bioavailability in PCOS: A Randomized Placebo-Controlled Trial.
Irani M; Seifer DB; Grazi RV; Julka N; Bhatt D; Kalgi B; Irani S; Tal O; Lambert-Messerlian G; Tal R
J Clin Endocrinol Metab; 2015 Nov; 100(11):4307-14. PubMed ID: 26485217
[TBL] [Abstract][Full Text] [Related]
31. Green cardamom plus low-calorie diet can decrease the expression of inflammatory genes among obese women with polycystic ovary syndrome: a double-blind randomized clinical trial.
Cheshmeh S; Ghayyem M; Khamooshi F; Heidarzadeh-Esfahani N; Rahmani N; Hojati N; Mosaieby E; Moradi S; Pasdar Y
Eat Weight Disord; 2022 Mar; 27(2):821-830. PubMed ID: 34057705
[TBL] [Abstract][Full Text] [Related]
32. Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review.
Menichini D; Facchinetti F
Gynecol Endocrinol; 2020 Jan; 36(1):1-5. PubMed ID: 31187648
[TBL] [Abstract][Full Text] [Related]
33. A Trial on The Effects of Magnesium-Zinc-Calcium-Vitamin D Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome.
Jamilian M; Maktabi M; Asemi Z
Arch Iran Med; 2017 Oct; 20(10):640-645. PubMed ID: 29137465
[TBL] [Abstract][Full Text] [Related]
34. The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
Nasri K; Jamilian M; Rahmani E; Bahmani F; Tajabadi-Ebrahimi M; Asemi Z
BMC Endocr Disord; 2018 Apr; 18(1):21. PubMed ID: 29649996
[TBL] [Abstract][Full Text] [Related]
35. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
[TBL] [Abstract][Full Text] [Related]
36. The effects of vitamin D and evening primrose oil co-supplementation on lipid profiles and biomarkers of oxidative stress in vitamin D-deficient women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
Nasri K; Akrami S; Rahimi M; Taghizadeh M; Behfar M; Mazandaranian MR; Kheiry A; Memarzadeh MR; Asemi Z
Endocr Res; 2018 Feb; 43(1):1-10. PubMed ID: 28742409
[TBL] [Abstract][Full Text] [Related]
37. High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial.
Raja-Khan N; Shah J; Stetter CM; Lott ME; Kunselman AR; Dodson WC; Legro RS
Fertil Steril; 2014 Jun; 101(6):1740-6. PubMed ID: 24636395
[TBL] [Abstract][Full Text] [Related]
38. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Foroozanfard F; Talebi M; Samimi M; Mehrabi S; Badehnoosh B; Jamilian M; Maktabi M; Asemi Z
Horm Metab Res; 2017 Aug; 49(8):612-617. PubMed ID: 28679142
[TBL] [Abstract][Full Text] [Related]
39. Influence of Vitamin D on the Incidence of Metabolic Syndrome and Hormonal Balance in Patients with Polycystic Ovary Syndrome.
Lejman-Larysz K; Golara A; Baranowska M; Kozłowski M; Guzik P; Szydłowska I; Nawrocka-Rutkowska J; Sowińska-Przepiera E; Cymbaluk-Płoska A; Brodowska A
Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447279
[TBL] [Abstract][Full Text] [Related]
40. Clinical and Metabolic Responses to Magnesium Supplementation in Women with Polycystic Ovary Syndrome.
Farsinejad-Marj M; Azadbakht L; Mardanian F; Saneei P; Esmaillzadeh A
Biol Trace Elem Res; 2020 Aug; 196(2):349-358. PubMed ID: 31960275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
